| Literature DB >> 32900904 |
Yan Zhou1,2, Jie Liu1,2, Qiuxia Lei1,2, Haixia Han1,2, Wei Liu1,2, Tang Cunwei3, Fuwei Li4,2, Dingguo Cao4,2.
Abstract
As a class of transcription regulators, numerous miRNAs have been verified to participate in regulating ovary follicular development in chickens (Gallus gallus). Previously we showed that gga-miR-135a-5p has significant differential expression between high and low-yield chicken ovaries, and the abundance of gga-miR-135a-5p is significantly higher in follicular theca cells than in granulosa cells. However, the exact role of gga-miR-135a-5p in chicken follicular theca cells is unclear. In this study, primary chicken follicular theca cells were isolated and then transfected with gga-miR-135a-5p inhibitor. Transcriptome sequencing was performed in chicken follicular theca cells with or without transfection. Differentially expressed genes (DEGs) were analyzed using bioinformatics. A dual-luciferase reporter assay was used to verify the target relationship between gga-miR-135a-5p and predicted targets within the DEGs. Compared with the normal chicken follicle theca cells, 953 up-regulated and 1060 down-regulated genes were detected in cells with gga-miR-135a-5p inhibited. The up-regulated genes were significantly enriched in Gene Ontology terms and pathways involved in cell proliferation and differentiation. In chicken follicular theca cells, Krüppel-like factor 4 (KLF4), ATPase phospholipid transporting 8A1 (ATP8A1), and Complexin-1 (CPLX1) were significantly up-regulated when the expression of gga-miR-135a-5p was inhibited. In addition, KLF4, ATP8A1, and CPLX1 confirmed as targets of gga-miR-135a-5p by using a dual-luciferase assay in vitro The results suggest that gga-mir-135a-5p may involve in proliferation and differentiation in chicken ovarian follicular theca cells by targeting KLF4, ATP8A1, and CPLX1.Entities:
Keywords: Gallus gallus; gga-miR-135a-5p; ovarian theca cells; transcriptome sequencing
Mesh:
Substances:
Year: 2020 PMID: 32900904 PMCID: PMC7642930 DOI: 10.1534/g3.120.401701
Source DB: PubMed Journal: G3 (Bethesda) ISSN: 2160-1836 Impact factor: 3.154
Information of the primers used for quantitative real-time PCR validation
| Genes | Tm(°C) | Sequences (5′-3′) | Products (bp) |
|---|---|---|---|
| 60 | F: GAAGAACCCAACAACCCAGA | 127 | |
| R: GTTTCAGTGCACGCTTCAGA | |||
| 60 | F:AAGCCGGTTTCACTTCCTCT | 135 | |
| R: CTTTGGCACCCATTTCTTGT | |||
| 60 | F:GCAGATCAGATGGCAAAGGT | 131 | |
| R: AGGCACGGTGATTTGATAGG | |||
| 60 | F: TTTCAGCGAGAAGAGCACAA | 119 | |
| R: TGACCACAACCTTGTCAGGA | |||
| 60 | F: TGCTCCTCACCAAAGATGTG | 120 | |
| R: CCAGCATTCCTGCTTCTAGC | |||
| 60 | F: AGGGCCAACATTAAGCACCTC | 110 | |
| R: TTTAGCTTGGGATCAATGCACAC | |||
| 60 | F: GGGAACGTGACTAAGCCCACA | 172 | |
| R: TGTCTCCATCCAGGGTCACAAC | |||
| 60 | F: CTGCGGCAAGACCTACACCA | 123 | |
| R: AGTTCATCAGATCGGGCAAACTTC | |||
| 60 | F:TCTAACTGTGTGTTTGAAGGCTGGA | 145 | |
| R: ATCGGGTGCCATAGGGATGA | |||
| 60 | F: GGATCGACCTGATGCCTTTGA | 137 | |
| R: CGTTGCACGTAATGGAGATGATG | |||
| 60 | F: AAGGACAACGCCACCATTGAG | 102 | |
| R: TGCAGCCAGTTCAAACACCAC | |||
| 60 | F:AGATGTTGAAGCCGAAGTACCC | 106 | |
| R: CTGAAGTCCTCCCTGCCTGT | |||
| 60 | F: TAAGCGTGTTATCATCTC | 86 | |
| R: GGGACTTGTCATATTTCT |
Primers for the construction of dual-luciferase reporter plasmid
| Genes | Primers (5′-3′) | Products (bp) |
|---|---|---|
| ATP8A1 | ATP8A1_WT _F: GCGGCTCGAGAGCACTTGTAGTTCTGATG | 687 |
| ATP8A1_WT _R: AATGCGGCCGCACATAGCGACCACTTTCTG | ||
| ATP8A1_mut_F: TAGAACTGTTCGGTATAATGCACTAATATTGTTT | ||
| ATP8A1_mut_R: AGTGCATTATACCGAACAGTTCTACAATAAAGAA | ||
| CPLX1 | CPLX1_WT _F: GCGGCTCGAGTGAACAAGACCAAAGATAA | 781 |
| CPLX1_WT- R _R: AATGCGGCCGCACAGAGAGAGAAAACAAGC | ||
| CPLX1_mut_F: TTTAGAGATTCGGTATTGAAATCAGACTGCAATA | ||
| CPLX1_mut_R: TGATTTCAATACCGAATCTCTAAAGATAGGTATG | ||
| KLF4 | KLF4_WT _F: GCGGCTCGAGATCACCTCGCCTTACACAT | 1033 |
| KLF4_WT _R: AATGCGGCCGCTCAACCACTGACCAACATT | ||
| KLF4_mut_F: CCTTCTAATTCGGTATACAATGTTAAAAGAGGA | ||
| KLF4_mut_R: ACATTGTATACCGAATTAGAAGGAAGAAAAAAA |
Note: WT, wild type; MUT, mutant type.
Figure 1The relative expression level of gga-miR-135a-5p in NG, TG and NC. ** P < 0.01. NG: follicular theca cells; TG: inhibitor transfected cells; NC: negative control.
Figure 2The expression level of the top 22 up-regulated genes with the most significant differential expression greater than fourfold between cells with normal and inhibited expression of gga-miR-135a-5p.
Figure 3Volcano plot of differentially expressed genes in cells with normal and inhibited expression of gga-miR-135a-5p. The X-axis represents log2 (FC) and Y -axis represents –log10 (FDR). The green dots indicate the down-regulated genes, the black dots indicate the genes with no significant differences, and the red dots indicate up-regulated genes.
Figure 4The heatmap of differentially expressed genes across all samples via Illumina sequencing. The depth of the color represents the level of gene expression in samples. Normal group: T07 and T08; Transfected group: T10, T11, and T12.
Figure 5GO annotation of differentially expressed genes,The y-axis on the left indicates the percentage of genes in each term, the x-axis indicates the enriched GO terms.
Figure 6KEGG annotation of up- regulated differentially expressed genes.
Figure 7Relative expression of 12 DEGs between cells with normal (NG) and inhibited (TG) expression of gga-miR-135a-5p.
Figure 8gga-miR-135a suppresses the expression of KLF4, ATP8A1, and CPLX1 in 293T cells. **P < 0.01.